AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Pretax margin (%)

Nxera Pharma Co., Ltd.【JP:4565】

Market cap
¥74.5B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Dec 31, 20252.4-114.89%
Dec 31, 2024-16.2-80.67%
Dec 31, 2023-83.7-1308.25%
Dec 31, 20226.9+183.23%
Dec 31, 20212.4-86.67%
Dec 31, 202018.3+234.11%
Dec 31, 20195.5-102.18%
Dec 31, 2018-252.2+373.80%
Mar 31, 2018-53.2-180.59%
Mar 31, 201766-263.28%
Mar 31, 2016-40.4-214.13%
Mar 31, 201535.4-0.51%
Mar 31, 201435.6-27.04%
Mar 31, 201348.8-121.58%
Mar 31, 2012-226.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)